
- Telehealth Visits
- Insurance plan information


Christina Louie Nakamura, NP
Family Medicine- Telehealth Visits
- Insurance plan information




Christina Louie Nakamura, NP
Family Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Christina Louie Nakamura is a family nurse practitioner with special interests in diabetes, high blood pressure, nutrition counseling and preventive medicine. Her goal is to empower patients to take charge of their own well-being and to make health decisions that will positively impact their lives.
Louie Nakamura believes passionately that health is a fundamental human right. She is committed to the idea that all people have equal worth and deserve to be treated with dignity.
Louie Nakamura earned her bachelor's and master's degrees in nursing at Columbia University, where she completed the Family Nurse Practitioner Program. For the six years before she joined UCSF, she practiced family medicine, providing primary care for predominantly Spanish-speaking patients in East Los Angeles. She belongs to the American Association of Nurse Practitioners.
A Bay Area native, Louie Nakamura enjoys running, photography, traveling and exploring San Francisco's many neighborhoods.
Education & training
Board certification
- Family Nurse Practitioner, American Nurses Cred Ctr-Family Nurse Practitioner
Degree
- MSN, Columbia University Program in Nursing
My expertise
Specialties
- Family Medicine
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%223391%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223391%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.